Rationale for the use of metronomic chemotherapy in gastrointestinal cancer

Expert Opinion on Pharmacotherapy
Roberto FilippiFrancesco Leone

Abstract

Metronomic chemotherapy (mCT) is endowed with various properties, ranging from antiangiogenic to immunomodulation, and may revert tumor resistance to conventional drug administration. A variety of antineoplastic agents displayed activity when administered with metronomic schedules in preclinical models of gastrointestinal cancers. However, most of the field is still unexplored. Herein, the authors review the existing literature from PubMed, concerning the use of mCT in gastrointestinal oncology. A mounting body of evidence is emerging in support of mCT as a treatment option for gastrointestinal tumors, but the frequent signs of clinical activity inconsistently translate into a benefit for survival. Research in this field should focus on providing high-quality evidence on the safety and efficacy of mCT, with more prospective, comparative trials; identifying the subgroups of patients for whom mCT would be the best approach; establishing standardized protocols based on mCT pharmacokinetics and pharmacodynamics; developing drug activity biomarkers. mCT is also potentially suitable for combinations with targeted antiangiogenic drugs and may be incorporated with conventional administration into dual regimens.

References

Jun 13, 2000·Cancer Biotherapy & Radiopharmaceuticals·D H LauA T Cheung
Jun 12, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R G AmadoP J Rosen
Oct 17, 2003·Proceedings of the National Academy of Sciences of the United States of America·Guido BocciRobert S Kerbel
Jun 2, 2004·Nature Reviews. Cancer·Robert S Kerbel, Barton A Kamen
Jun 4, 2004·The New England Journal of Medicine·Herbert HurwitzFairooz Kabbinavar
Nov 24, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kristian Pietras, Douglas Hanahan
Jun 21, 2005·Nature Reviews. Cancer·John J Kim, Ian F Tannock
May 19, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Scott D YoungColin J Germond
Jul 22, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sylvia S W NgRobert S Kerbel
Nov 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eric Van CutsemUNKNOWN V325 Study Group
Mar 14, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D H IlsonD P Kelsen
Feb 1, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles S FuchsJosé Barrueco
Mar 19, 2008·Molecular Cancer Therapeutics·Berta LaquenteFrancesc Viñals
Jul 22, 2008·Journal of Cancer Research and Clinical Oncology·G TreiberP Malfertheiner
Jul 25, 2008·The New England Journal of Medicine·Josep M LlovetUNKNOWN SHARP Investigators Study Group
Jan 27, 2009·Proceedings of the National Academy of Sciences of the United States of America·KangAe LeeGregg L Semenza
Aug 22, 2009·European Journal of Pharmacology·Anna FioravantiGuido Bocci
Aug 22, 2009·International Journal of Cancer. Journal International Du Cancer·Martin E EichhornMarc Dellian
Sep 10, 2009·Cancer Biology & Therapy·William M MerrittAnil K Sood
Feb 10, 2010·Laboratory Investigation; a Journal of Technical Methods and Pathology·Dongshan ZhangYashpal S Kanwar
Apr 9, 2010·The New England Journal of Medicine·Juan ValleUNKNOWN ABC-02 Trial Investigators

❮ Previous
Next ❯

Citations

Sep 25, 2019·Expert Opinion on Pharmacotherapy·Roberto FilippiMassimo Aglietta
May 1, 2021·Geriatrics·Antonino C TralongoMarco Danova
Jul 3, 2021·Journal of Clinical Medicine·Nai-Wen Su, Yu-Jen Chen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Nature Reviews. Clinical Oncology
Eddy PasquierNicolas André
Current Oncology Reports
Hanspreet Kaur, G Thomas Budd
Expert Opinion on Investigational Drugs
Rossana RuizChristian Rolfo
© 2022 Meta ULC. All rights reserved